PTGS2 and cancer: Similarly, strong to moderate cytoplasmic COX2 staining and occasional membranous reactivity is observed in 50% of all cancers, including colorectal, prostate, cervical, endometrial, urothelial, pancreatic, liver and in glandular cells from gastric tumor tissue.